Skip to main content

Table 4 Clinical features analysis

From: Genetic and biochemical studies in Argentinean patients with variegate porphyria

  N° (%) Subjects from      
Symptomatology Present Study (n: 72) South Africaa (n: 269) Souh Africab (n: 11) Western Europe c (n: 103) Finlandd
      Before 1980 (n: 34) After 1980 (n: 20)
Acute 20 (28) 51 (19) 0 (0) 20 (20) 10 (29) 3 (15)
Cutaneous 25 (35) 156 (58) 10 (91) 61 (59) 14 (42) 13 (65)
Both 27 (37) 62 (23) 1 (9) 22 (21) 10 (29) 4 (20)
Asymptomatic 15 (29) 31 (10) 17 (61) ---------- 19 (36) 30 (60)
Acute 20 (28) 51 (19) 0 (0) 20 (20) 10 (29) 3 (15)
Cutaneous 25 (35) 156 (58) 10 (91) 61 (59) 14 (42) 13 (65)
Both 27 (37) 62 (23) 1 (9) 22 (21) 10 (29) 4 (20)
Asymptomatic 15 (29) 31 (10) 17 (61) ---------- 19 (36) 30 (60)
Acute 20 (28) 51 (19) 0 (0) 20 (20) 10 (29) 3 (15)
Cutaneous 25 (35) 156 (58) 10 (91) 61 (59) 14 (42) 13 (65)
Both 27 (37) 62 (23) 1 (9) 22 (21) 10 (29) 4 (20)
Asymptomatic 15 (29) 31 (10) 17 (61) ---------- 19 (36) 30 (60)
  1. The total number of symptomatic subjects were considered
  2. a: Eales et al (1980), b: Hift et al, 2004, c: Whatley et al, 1999, d: von und zu Fraunberg et al, 2000.